Gilead Sciences has granted royalty-free licenses to six generic drug manufacturers for the HIV prevention drug lenacapavir in 120 low-income countries.
Gilead grants licenses for generic HIV drug production
Original Article by Reuters | 3 October 2024
Gilead Sciences has granted royalty-free licenses to six generic drug manufacturers for the HIV prevention drug lenacapavir in 120 low-income countries.